Biogen Inc.
BIIB · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $9.89B | $9.68B | +2.2% |
| Operating income | $1.86B | $2.25B | −17.2% |
| Net income | $1.29B | $1.63B | −20.8% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 28, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $2.80B | $2.53B | +10.6% |
| Operating income | −$9.00M | $557M | |
| Net income | −$20.6M | $466M |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Biogen's revenue in FY2025?
- $9.89B in FY2025 (Fiscal year ended Dec 31, 2025), +2.2% vs $9.68B a year earlier, per its 10-K filed Feb 2026.
- Was Biogen profitable in FY2025?
- Yes: net income was $1.29B and operating income $1.86B in FY2025.
- What was Biogen's revenue in Q3 2026?
- $2.80B (+10.6% vs a year earlier), per its Form 10-Q filed Oct 28, 2026.